NCEP ATP III
COMPARISON OF PREVALENCE PATTERN OF METABOLIC SYNDROME COMPONENTS BY WHO, EGIR, IDF, NCEP-ATP III AND AHA-NHLBI DEFINITIONS IN HYPERTENSIVE PATIENTS VISITING A TERTIARY CARE HOSPITAL IN ANDHRA PRADESH
... BACKGROUNDS: To reduce the incidence of cardiovascular disease(CVD) and Type2Diabetes(T2DM), early identification of metabolic syndrome(MetS) is important which provoked us to do this study. OBJECTIVES: To assess and ...
6
Prevalence of metabolic syndrome in type 2 diabetic patients: A comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions
... and NCEP ATP III definitions of ...to NCEP ATP III definition in classify- ing our type 2 diabetic patients having or not having ...Likewise, NCEP ATP III ...
8
METABOLIC SYNDROME: PREVALENCE (IDF & NCEP ATP III) IN UDHAMPUR, JAMMU CITY
... There have been several definitions of MetS, but the most commonly used standards for definition at present are from the World Health Organization (WHO), the European Group for the study of Insulin Resistance, the ...
6
A Comparative study of Rosuvastatin and Fenofibrate as Monotherapy in Dyslipidemia and NCEP ATP III Goals
... It has been seen that both the drugs significantly achieved the set goals as per NCEP-ATP III for dyslipidemic patients. But their effects are variable on the different parameters of lipid profile. ...
6
Update on the NCEP ATP-III emerging cardiometabolic risk factors
... The intent of this review is to update the science of emerging cardiometabolic risk factors that were listed in the National Cholesterol Education Program (NCEP) Adult Treatment Panel-III ...
9
Prevalence of Metabolic Syndrome in HIV Infected Cameroonian Patients
... Panel III (NCEP ATP III) and International Diabetes Federation (IDF) ...to NCEP ATP III [16], metabolic syndrome was defined as having ≥3 of the following criteria: ...
8
Prevalence of the metabolic syndrome in a rural population in Ghana
... fellow researchers in Nigeria determined a rate of 12.7% (NCEP ATP III) that was much close to findings in our study [16]. Studies in the US [8,12,15] and Europe [19-25] revealed higher rates but for ...
9
Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions
... Patients and methods: The study was conducted on 100 healthy subjects aged between 6 and 16 years (average age, 10.52 ± 2.51 years) with a high BMI for their age and sex. Fifty-eight percent of subjects were female. ...
9
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
... Anthropometric and metabolic parameters were recorded accurately at the time of admission after patients had been consented for data collection, sharing and archiving. Body Mass Index (BMI) (kg/m 2 ) was calculated from ...
6
The Prevalence of Metabolic Syndrome in an Apparently Healthy, Normotensive and Non Diabetic Population in Saudi Arabia by Two Definitions: Implications for Local Practice
... the NCEP-ATP III criteria to test for agreement in classification, and to determine the characteristics of subjects identified by either definition, and 2) examine the significance of family medi- ...
7
PubMedCentral-PMC5524073.pdf
... following NCEP/ATP III updated guidelines 12 and ACC/AHA ...2004 NCEP/ATP III guidelines, statin-eligible participants included participants with (1) prevalent coronary heart ...
15
Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes
... We have calculated SENS, SPEC, PPV, and NPV at differ- ent cutoffs for triglycerides (in the overall population) and for waist and HDL in females, to assess the specificity for MS diagnosis according to the NCEP ...
5
Drug Emergent Metabolic syndrome in patients on Antipsychotic Medication
... The incidence of metabolic syndrome using the NCEP ATP III criteria among the patients followed up is 7%. This corresponds with incidence rate of 11% reported by another recent study from northern ...
141
A Prospective Study on Metabolic Syndrome in Patients with Cardiovascular Disease.
... revised NCEP ATP III and IDF and to study the impact of different variables such as age, gender, Body Mass Index (BMI), WC, Fasting Blood Sugar (FBS), High Density Lipoprotein cholesterol (HDL-c), ...
80
Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines
... CHD: coronary heart disease; CVD: cardiovascular disease; LDL: low-density lipoprotein; LDL-C: low-density lipoprotein cholesterol; MI: myocardial infarction; NCEP ATP-III: National Chol[r] ...
16
Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics results from a German observational study
... Several limitations of this study should be considered: As the study did not reach the required sample size, the analyses were underpowered, and therefore logistic regression models might have failed to detect all ...
11
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
... Even though there is a considerable variation in meth- odology and criteria among published studies, the MS prevalence in our study was within the range of prior reports published regionally and worldwide [36-42]. ...
8
Click here to download PDF version of the article !
... using NCEP ATP III PANEL (National cholesterol education programme, adult training programme III) definition [21] and presence of metabolic syndrome was confirmed when three or more of the ...
5
Metabolic syndrome among students attending a historically black college: prevalence and gender differences
... American; NCEP- ATP III: National Cholesterol Education Program ’ s Adult Treatment Panel III; CHD: Coronary Heart Disease; US: United States; NHANES: National Health Awareness and Nutrition ...
8
Prevalence of metabolic syndrome among obese diabetic subjects
... using NCEP-ATP III definition (Hydrie MZI, 2009)and 46% in T2DM subjects (Sohail SMA, 206) Therefore, the aim of the present study is to investigate the prevalence of MS in obese T2DM subjects by ...
6